GlaxoSmithKline, the British drug maker secured the US research partner Human Genome Sciences Inc. after raising its bid to (Dollar) 3.0 billion (2.4 billion euros). GSK said in a statement that it won approval from HGS management after lifting its bid to (Dollar) 14.25 per share in cash from (Dollar) 13 per. "GlaxoSmithKline Plc and Human Genome Sciences today announced that the companies have entered into a definitive agreement under which GSK will acquire HGS for (Dollar) 14.25 per ...via Medindia Health News More READ
No comments:
Post a Comment